These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1820926)

  • 21. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H; Quentin C; de Barbeyrac B; Bebear C
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ionization constants and partition coefficients of 1-arylpiperazine derivatives.
    Caccia S; Fong MH; Urso R
    J Pharm Pharmacol; 1985 Aug; 37(8):567-70. PubMed ID: 2864419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biopharmaceutical studies on hydantoin derivatives. I. Physico-chemical properties of hydantoin derivatives and their intestinal absorption.
    Fujioka H; Tan T
    J Pharmacobiodyn; 1981 Oct; 4(10):759-70. PubMed ID: 7320829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity coefficients and partition coefficients as parameters for the evaluation of biological activity. A linear relationship between log "gamma" and log P.
    Avico U; Signoretti EC; Zuccaro P
    Farmaco Sci; 1980 Jul; 35(7):590-5. PubMed ID: 7450048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro and in vivo antibacterial activities of a new quinolone derivative, FD501].
    Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
    Jpn J Antibiot; 1996 Mar; 49(3):264-72. PubMed ID: 8935122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrochemical studies of some quinolone antibiotics. Part I. Qualitative analysis on mercury and carbon electrodes.
    Warowna-Grześkiewicz M; Chodkowski J; Fijałek Z
    Acta Pol Pharm; 1995; 52(3):187-92. PubMed ID: 8960249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical parameters and biological activity of sulfonamides.
    Avico U; Zuccaro P; Cingolani E; Ciranni Signoretti E
    Farmaco Sci; 1985 Dec; 40(12):970-8. PubMed ID: 4092768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protonation equilibria of quinolone antibacterials.
    Takács-Novák K; Noszál B; Hermecz I; Keresztúri G; Podányi B; Szász G
    J Pharm Sci; 1990 Nov; 79(11):1023-8. PubMed ID: 1963448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium.
    Sun J; Sakai S; Tauchi Y; Deguchi Y; Chen J; Zhang R; Morimoto K
    Eur J Pharm Biopharm; 2002 Jul; 54(1):51-8. PubMed ID: 12084502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurements of ionization constants and partition coefficients of quanazole prodrugs.
    Alhaider AA; Selassie CD; Chua SO; Lien EJ
    J Pharm Sci; 1982 Jan; 71(1):89-94. PubMed ID: 7057389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of quinolone antibiotics in urine by capillary electrophoresis with chemiluminescence detection.
    Liu YM; Jia YX; Tian W
    J Sep Sci; 2008 Dec; 31(21):3765-71. PubMed ID: 19003804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.
    Kastner M; Rahm U; Baumann-Wilschke I; Bello A; Stahlmann R
    Arch Toxicol; 2004 Feb; 78(2):61-7. PubMed ID: 14661070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ionization constants, octanol partition coefficients and cholinesterase inhibitor constants for chlorpromazine and its metabolites.
    Whelpton R
    J Pharm Pharmacol; 1989 Dec; 41(12):856-8. PubMed ID: 2576450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of povidone with aromatic compounds. VI: Use of partition coefficients (log Kd) to correlate with log P values and apparent Kd values to express the binding as a function of pH and pKa.
    Plaizier-Vercammen JA
    J Pharm Sci; 1987 Oct; 76(10):817-20. PubMed ID: 3430347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical evolution of the fluoroquinolone antimicrobial agents.
    Neu HC
    Am J Med; 1989 Dec; 87(6C):2S-9S. PubMed ID: 2557762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of hydrophobicity with protein binding for clorobiocin analogs.
    Coulson CJ; Smith VJ
    J Pharm Sci; 1980 Jul; 69(7):799-801. PubMed ID: 7391943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.